Study uses cellulose sheets to map body’s extracellular vesicles, unlocking disease insights

Study demonstrates the use of cellulose nanofiber sheets for spatial analysis of extracellular vesicles, revealing their geographical heterogeneity in the human body, which could advance the understanding and treatment of diseases.

Subcutaneous Amivantamab Plus Lazertinib Non-Inferior to IV Dosing in NSCLC

CHICAGO — Subcutaneous amivantamab (Rybrevant) was non-inferior to IV amivantamab for pre-treated patients with refractory EGFR-mutated, advanced non-small cell lung cancer (NSCLC), with the suggestion

June 2, 2024

Adaptimmune’s Tecelra gains accelerated approval for synovial sarcoma – Pharmaceutical Technology

Tecelra is genetically engineered to target melanoma-associated antigen A4 (MAGE-A4). Image: Shutterstock/Christoph Burgstedt Oxford-based cell therapy company Adaptimmune Therapeutics has received accelerated approval from the

August 2, 2024

4DMT secures rare paediatric designation for cystic fibrosis gene therapy – Pharmaceutical Technology

Share this article Around 40,000 children and adults in the US alone live with the disease that causes severe damage to the lungs. Image credit:

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.